Our latest article has been published in Nature Communications. The study focuses on the identification of lysyl oxidase (LOX) protein as a major chemotherapy resistance modulator in triple negative breast cancer. We showed that targeting LOX overcomes chemoresistance in TNBC.

Read the article here.

Categories: Publication


Leave a Reply

Avatar placeholder

Your email address will not be published. Required fields are marked *